{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:02:39Z","timestamp":1787580159280,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Chronic hematological malignancies progress slowly, potentially manifesting symptoms spanning months to years. HM-PRO is developed as a comprehensive clinical tool for assessing symptoms in hematology. The aim was to investigate the effect of a nurse-led systematic approach to symptom identification and management using HM-PRO in outpatient care in patients with chronic hematological malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a randomized trial including 94 patients to investigate an intervention comprising (1) HM-PRO data collection, (2) HM-PRO assessment guided by an algorithm, and (3) nurse-led tailored symptom management. The control arm received standard follow-up care. The primary outcome was change in QoL. Secondary outcomes were change in prevalence of physical and psychological symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A statistically significant difference in QoL change scores over time favored the intervention (diff. 10.3; <jats:italic>p<\/jats:italic>\u2009=\u2009.04). For secondary endpoints, a significant between group difference in change over time for severity scores was observed in fatigue (diff.\u2009\u2212\u200913.6; <jats:italic>p<\/jats:italic>\u2009=\u2009.003), overall symptom burden (diff.\u2009\u2212\u20090.7 points; <jats:italic>p<\/jats:italic>\u2009=\u2009.029), emotional functioning (diff. 10.0; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.0001), and anxiety (diff.\u2009\u2212\u20092.5; <jats:italic>p<\/jats:italic>\u2009=\u2009.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A 12-month nurse-led symptom management intervention within hematology significantly improved QoL, emotional functioning, fatigue, anxiety, and overall symptom burden over time. This is the first randomized trial investigating nurse-led clinical application of the HM-PRO questionnaire providing knowledge on the efficacy of systematic symptom management in clinical practice. This study highlights both the pivotal role of nurses and multidisciplinary support and the inherent value of tailored symptom management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinical trial registration number: NCT04757545 (02\/12\/2021).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09230-1","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T09:08:26Z","timestamp":1739610506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of nurse-led symptom management in chronic myeloid malignancies: a randomized trial"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-8897","authenticated-orcid":false,"given":"Maja","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Torp","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Thomas","family":"Kornblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Ove","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-3508","authenticated-orcid":false,"given":"Kirsten","family":"Lomborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-9889","authenticated-orcid":false,"given":"Anders","family":"Tolver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3040-8384","authenticated-orcid":false,"given":"Mary","family":"Jarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"9230_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte D, Jansen L, Brenner H (2020) Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J 10:56. https:\/\/doi.org\/10.1038\/s41408-020-0323-4","journal-title":"Blood Cancer J"},{"issue":"Suppl 1","key":"9230_CR2","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","volume":"18","author":"D Rodriguez-Abreu","year":"2007","unstructured":"Rodriguez-Abreu D, Bordoni A, Zucca E (2007) Epidemiology of hematological malignancies. Ann Oncol 18(Suppl 1):i3\u2013i8. https:\/\/doi.org\/10.1093\/annonc\/mdl443","journal-title":"Ann Oncol"},{"key":"9230_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00277-016-2730-y","volume":"95","author":"A Kaifie","year":"2016","unstructured":"Kaifie A, Isfort S, Gattermann N et al (2016) Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians. Ann Hematol 95:1399\u20131410. https:\/\/doi.org\/10.1007\/s00277-016-2730-y","journal-title":"Ann Hematol"},{"key":"9230_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3324\/haematol.2016.149559","volume":"102","author":"HL Geyer","year":"2017","unstructured":"Geyer HL, Kosiorek H, Dueck AC et al (2017) Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group. Haematologica 102:85\u201393. https:\/\/doi.org\/10.3324\/haematol.2016.149559","journal-title":"Haematologica"},{"key":"9230_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpainsymman.2010.12.008","volume":"42","author":"V Manitta","year":"2011","unstructured":"Manitta V, Zordan R, Cole-Sinclair M et al (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage 42:432\u2013442. https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.12.008","journal-title":"J Pain Symptom Manage"},{"key":"9230_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/0284186X.2014.958527","volume":"54","author":"AW Boyes","year":"2015","unstructured":"Boyes AW, Clinton-McHarg T, Waller AE et al (2015) Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy. Acta Oncol 54:507\u2013514. https:\/\/doi.org\/10.3109\/0284186X.2014.958527","journal-title":"Acta Oncol"},{"key":"9230_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.critrevonc.2010.01.004","volume":"77","author":"A Mehnert","year":"2011","unstructured":"Mehnert A (2011) Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 77:109\u2013130. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.01.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"9230_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11899-017-0399-5","volume":"12","author":"H Geyer","year":"2017","unstructured":"Geyer H, Mesa RA (2017) Approach to MPN symptom assessment. Curr Hematol Malig Rep 12:381\u2013388. https:\/\/doi.org\/10.1007\/s11899-017-0399-5","journal-title":"Curr Hematol Malig Rep"},{"key":"9230_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.29","volume":"5","author":"P Allart-Vorelli","year":"2015","unstructured":"Allart-Vorelli P, Porro B, Baguet F et al (2015) Haematological cancer and quality of life: a systematic literature review. Blood Cancer J 5:e305. https:\/\/doi.org\/10.1038\/bcj.2015.29","journal-title":"Blood Cancer J"},{"key":"9230_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ejh.13048","volume":"100","author":"R Tolstrup Larsen","year":"2018","unstructured":"Tolstrup Larsen R, Tang LH, Brochmann N et al (2018) Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms. Eur J Haematol 100:550\u2013559. https:\/\/doi.org\/10.1111\/ejh.13048","journal-title":"Eur J Haematol"},{"key":"9230_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1200\/JCO.2013.48.6662","volume":"32","author":"DL Berry","year":"2014","unstructured":"Berry DL, Hong F, Halpenny B et al (2014) Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol 32:199\u2013205. https:\/\/doi.org\/10.1200\/JCO.2013.48.6662","journal-title":"J Clin Oncol"},{"key":"9230_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","volume":"26","author":"D Howell","year":"2015","unstructured":"Howell D, Molloy S, Wilkinson K et al (2015) Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol 26:1846\u20131858. https:\/\/doi.org\/10.1093\/annonc\/mdv181","journal-title":"Ann Oncol"},{"key":"9230_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1200\/EDBK_175418","volume":"37","author":"K Mooney","year":"2017","unstructured":"Mooney K, Berry DL, Whisenant M, Sjoberg D (2017) Improving cancer care through the patient experience: how to use patient-reported outcomes in clinical practice. Am Soc Clin Oncol Educ Book 37:695\u2013704. https:\/\/doi.org\/10.1200\/EDBK_175418","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"9230_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijnurstu.2018.05.014","volume":"86","author":"A Charalambous","year":"2018","unstructured":"Charalambous A, Wells M, Campbell P et al (2018) A scoping review of trials of interventions led or delivered by cancer nurses. Int J Nurs Stud 86:36\u201343. https:\/\/doi.org\/10.1016\/j.ijnurstu.2018.05.014","journal-title":"Int J Nurs Stud"},{"key":"9230_CR15","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00520-013-1892-6","volume":"21","author":"J de Leeuw","year":"2013","unstructured":"de Leeuw J, Larsson M (2013) Nurse-led follow-up care for cancer patients: what is known and what is needed. Support Care Cancer 21:2643\u20132649. https:\/\/doi.org\/10.1007\/s00520-013-1892-6","journal-title":"Support Care Cancer"},{"key":"9230_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ejh.13203","volume":"102","author":"P Goswami","year":"2019","unstructured":"Goswami P, Khatib Y, Salek S (2019) Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality-of-life instruments. Eur J Haematol 102:279\u2013311. https:\/\/doi.org\/10.1111\/ejh.13203","journal-title":"Eur J Haematol"},{"key":"9230_CR17","doi-asserted-by":"publisher","first-page":"204062072095500","DOI":"10.1177\/2040620720955002","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P, Oliva EN, Ionova T et al (2020) Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Ther Adv Hematol 11:204062072095500. https:\/\/doi.org\/10.1177\/2040620720955002","journal-title":"Ther Adv Hematol"},{"key":"9230_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00209","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P, Oliva EN, Ionova T et al (2020) Development of a novel hematological malignancy specific patient-reported outcome measure (HM-PRO): content validity. Front Pharmacol 11:209. https:\/\/doi.org\/10.3389\/fphar.2020.00209","journal-title":"Front Pharmacol"},{"key":"9230_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332","volume":"340","author":"Schulz KF, Altman DG, Moher D, CONSORT Group","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332. https:\/\/doi.org\/10.1136\/bmj.c332","journal-title":"BMJ"},{"key":"9230_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I, Moher D, Altman DG et al (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295\u2013309. https:\/\/doi.org\/10.7326\/0003-4819-148-4-200802190-00008","journal-title":"Ann Intern Med"},{"key":"9230_CR21","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1046\/j.1365-2648.2001.01697.x","volume":"33","author":"M Dodd","year":"2001","unstructured":"Dodd M, Janson S, Facione N et al (2001) Advancing the science of symptom management. J Adv Nurs 33:668\u2013676. https:\/\/doi.org\/10.1046\/j.1365-2648.2001.01697.x","journal-title":"J Adv Nurs"},{"key":"9230_CR22","volume-title":"Smith\u2019s patient centered interviewing: an evidence-based method","author":"AH Fortin","year":"2019","unstructured":"Fortin AH (2019) Smith\u2019s patient centered interviewing: an evidence-based method, 4th edn. McGraw-Hill Education, New York","edition":"4"},{"key":"9230_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"9230_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 4","key":"9230_CR25","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/s0959-8049(01)00448-8","volume":"38","author":"P Fayers","year":"2002","unstructured":"Fayers P, Bottomley A, EORTC Quality of Life Group, Quality of Life Unit (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(Suppl 4):S125-133. https:\/\/doi.org\/10.1016\/s0959-8049(01)00448-8","journal-title":"Eur J Cancer"},{"key":"9230_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"key":"9230_CR27","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v","volume":"89","author":"CS Cleeland","year":"2000","unstructured":"Cleeland CS, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory Cancer 89:1634\u20131646. https:\/\/doi.org\/10.1002\/1097-0142(20001001)89:7%3c1634::aid-cncr29%3e3.0.co;2-v","journal-title":"M.D Anderson Symp Invent Cancer"},{"key":"9230_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","volume":"188","author":"JZ Musoro","year":"2023","unstructured":"Musoro JZ, Coens C, Sprangers MAG et al (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types. Eur J Cancer 188:171\u2013182. https:\/\/doi.org\/10.1016\/j.ejca.2023.04.027","journal-title":"Eur J Cancer"},{"key":"9230_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00277-020-03921-x","volume":"99","author":"A Pahl","year":"2020","unstructured":"Pahl A, Wehrle A, Kneis S et al (2020) Whole body vibration training during allogeneic hematopoietic cell transplantation-the effects on patients\u2019 physical capacity. Ann Hematol 99:635\u2013648. https:\/\/doi.org\/10.1007\/s00277-020-03921-x","journal-title":"Ann Hematol"},{"key":"9230_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of life questionnaire core 30. J Clin Oncol 29:89\u201396. https:\/\/doi.org\/10.1200\/JCO.2010.28.0107","journal-title":"J Clin Oncol"},{"key":"9230_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Tholstrup D, Petersen MA et al (2009) Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol 83:139\u2013148. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01250.x","journal-title":"Eur J Haematol"},{"key":"9230_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/10428194.2020.1838509","volume":"62","author":"F Efficace","year":"2021","unstructured":"Efficace F, Iurlo A, Patriarca A et al (2021) Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. Leuk Lymphoma 62:669\u2013678. https:\/\/doi.org\/10.1080\/10428194.2020.1838509","journal-title":"Leuk Lymphoma"},{"key":"9230_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1569186118818680","volume":"31","author":"A Sagari","year":"2018","unstructured":"Sagari A, Ikio Y, Imamura N et al (2018) Effect of occupation-based interventions in patients with haematopoietic malignancies undergoing chemotherapy: a pilot randomised controlled trial. Hong Kong J Occup Ther 31:97\u2013105. https:\/\/doi.org\/10.1177\/1569186118818680","journal-title":"Hong Kong J Occup Ther"},{"key":"9230_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/cncr.32521","volume":"126","author":"HSL Jim","year":"2020","unstructured":"Jim HSL, Hyland KA, Nelson AM et al (2020) Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: results from a pilot randomized trial. Cancer 126:174\u2013180. https:\/\/doi.org\/10.1002\/cncr.32521","journal-title":"Cancer"},{"key":"9230_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00520-019-04932-9","volume":"28","author":"AL Bryant","year":"2020","unstructured":"Bryant AL, Coffman E, Phillips B et al (2020) Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation. Support Care Cancer 28:1223\u20131231. https:\/\/doi.org\/10.1007\/s00520-019-04932-9","journal-title":"Support Care Cancer"},{"key":"9230_CR36","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1097\/HCR.0000000000000379","volume":"39","author":"KR Lemay","year":"2019","unstructured":"Lemay KR, Tulloch HE, Pipe AL, Reed JL (2019) Establishing the minimal clinically important difference for the hospital anxiety and depression scale in patients with cardiovascular disease. J Cardiopulm Rehabil Prev 39:E6\u2013E11. https:\/\/doi.org\/10.1097\/HCR.0000000000000379","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"9230_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamaoncol.2020.6343","volume":"7","author":"A El-Jawahri","year":"2021","unstructured":"El-Jawahri A, LeBlanc TW, Kavanaugh A et al (2021) Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial. JAMA Oncol 7:238\u2013245. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6343","journal-title":"JAMA Oncol"},{"key":"9230_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1188\/22.ONF.105-112","volume":"49","author":"D Von Ah","year":"2022","unstructured":"Von Ah D, Cooley ME, Bailey DE Jr et al (2022) Oncology nursing symptom science: overview of the NINR, ONS, and NCI symptom science colloquium. Oncol Nurs Forum 49:105\u2013112. https:\/\/doi.org\/10.1188\/22.ONF.105-112","journal-title":"Oncol Nurs Forum"},{"key":"9230_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/17407745221093935","volume":"19","author":"BL King-Kallimanis","year":"2022","unstructured":"King-Kallimanis BL, Bhatnagar V, Horodniceanu EG et al (2022) Timing is everything: the importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events. Clin Trials 19:267\u2013273. https:\/\/doi.org\/10.1177\/17407745221093935","journal-title":"Clin Trials"},{"key":"9230_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1078","volume":"5","author":"B Daly","year":"2022","unstructured":"Daly B, Nicholas K, Flynn J et al (2022) Analysis of a remote monitoring program for symptoms among adults with cancer receiving antineoplastic therapy. JAMA Netw Open 5:e221078. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1078","journal-title":"JAMA Netw Open"},{"key":"9230_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jocn.15944","volume":"31","author":"HK Rossau","year":"2022","unstructured":"Rossau HK, Kjerholt M, Brochmann N et al (2022) Daily living and rehabilitation needs in patients and caregivers affected by myeloproliferative neoplasms (MPN): a qualitative study. J Clin Nurs 31:909\u2013921. https:\/\/doi.org\/10.1111\/jocn.15944","journal-title":"J Clin Nurs"},{"key":"9230_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jval.2019.04.1927","volume":"22","author":"LSE van Egdom","year":"2019","unstructured":"van Egdom LSE, Oemrawsingh A, Verweij LM et al (2019) Implementing patient-reported outcome measures in clinical breast cancer care: a systematic review. Value in Health 22:1197\u20131226. https:\/\/doi.org\/10.1016\/j.jval.2019.04.1927","journal-title":"Value in Health"},{"key":"9230_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/EDBK_159514","volume":"35","author":"PG Kluetz","year":"2016","unstructured":"Kluetz PG, Chingos DT, Basch EM, Mitchell SA (2016) Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute\u2019s Patient-Reported Outcomes Version of the common Terminology Criteria for Adverse Events (PRO-CTCAE). Am Soc Clin Oncol Educ Book 35:67\u201373. https:\/\/doi.org\/10.1200\/EDBK_159514","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09230-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:10:11Z","timestamp":1745842211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9230"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09230-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was registered with the Regional Ethics Committee for the Capital Region of Denmark (20070444) and received approval by the Danish Protection Agency (P-2020\u20131085).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}